Trending Topics
Zoll header_$.png

Nationwide, communities continue to battle the effects of the opioid crisis. Litigation brought by states against drug distributors, manufacturers and pharmacy chains has produced opioid settlement funding designed to bring relief to communities affected by the epidemic. The various funding mechanisms (how to request, how to apply and to who) is evolving and varies by state.

First responders are on the front line of this crisis treating overdose patients, securing illegal, dangerous drugs and managing the various scenarios related to opioid calls. For public safety agencies, including EMS, opioid settlement funding may be tapped for a variety of purposes. For this reason, public safety leaders must understand the basics of the settlements, how funds will be distributed and how your agency may be able to tap into funding in a responsible manner.

Follow our Opioid Settlement Funding: Compensation For Communities coverage, brought to you by ZOLL Medical, to stay informed.

Opioid settlement funds news and resources
Related news about the opioid crisis and improving patient outcomes
Alameda County, California, says they’ve found the “prescription for success” in improving cardiac arrest outcomes
Dr. Tom Rea Emergency Cardiovascular Care Update 2015 opening session challenged attendees to improve cardiac arrest survival in their community
The clinical trial aims to prove whether the drug is a viable option to reduce excess bleeding from traumatic brain injuries
New research showed that isopropyl alcohol relieved nausea symptoms for patients in the ER
Dr. Gordon Ewy presents findings on the importance of bystander CPR and patient gasping at the Emergency Cardiovascular Care Update 2015
Fire chief says strain on responders is a growing problem, mainly caused by young people drinking
The app-based service allows medics to transmit ECGs and patient information to physicians
An in-depth analysis of the research based updates for the treatment of out of hospital cardiac arrest
Quantitative waveform capnography can be a reliable surrogate for lactate monitoring in detecting metabolic distress in sepsis patients
Patient symptoms ranged from mild nausea, tachycardia and agitation to difficulty breathing and unconsciousness
About the Sponsor: ZOLL
ZOLL is a resuscitation solutions pioneer, distinguished by consistency in management, ownership, and approach for nearly 30 years. As a financially strong, public company, ZOLL has an enviable product quality and reliability record. ZOLL technologies to help advance the practice of resuscitation include pacing, defibrillation, circulation, ventilation, data management, and fluid resuscitation.

These comprehensive technologies help clinicians, EMS professionals, and lay rescuers resuscitate sudden cardiac arrest and trauma victims. ZOLL’s commitment is to be the dependable choice for all providers in the field of resuscitation.

ZOLL markets and sells its products, including AED Plus®, AED Pro®, the R Series™ defibrillator, the AutoPulse® non-invasive cardiac support pump, and the LifeVest® wearable defibrillator in more than 140 countries. The Company has direct operations, distributor networks, and business partners throughout the U.S., Canada, Latin America, Europe, the Middle East and Africa, Asia, and Australia.